Literature DB >> 35726616

Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.

Lucy S Witt1,2, Danielle Barrios Steed1, Eileen M Burd1,3,4, Tugba Ozturk4, Michelle H Davis4, Sarah W Satola1,2,3,4, David S Weiss1,2,4, Jesse T Jacob1,2,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35726616     DOI: 10.1093/jac/dkac197

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.758


× No keyword cloud information.
  1 in total

1.  Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.

Authors:  Christopher M Longshaw; Anne Santerre Henriksen; Christine Slover; Yoshinori Yamano; J Andreas Karas
Journal:  J Antimicrob Chemother       Date:  2022-09-30       Impact factor: 5.758

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.